PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 42 filers reported holding PROTARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,503 | -30.1% | 18,864 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $45,085 | -23.6% | 18,864 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $59,044 | +16.8% | 18,864 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $50,556 | -9.7% | 18,864 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $56,000 | -25.3% | 18,864 | -26.5% | 0.00% | -50.0% |
| Q2 2022 | $75,000 | -46.8% | 25,666 | -7.0% | 0.00% | -33.3% |
| Q1 2022 | $141,000 | -24.2% | 27,591 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $186,000 | -43.3% | 27,591 | -41.8% | 0.00% | -55.6% |
| Q3 2021 | $328,000 | -40.8% | 47,423 | -16.6% | 0.01% | -50.0% |
| Q2 2021 | $554,000 | -39.5% | 56,883 | -2.3% | 0.02% | -47.1% |
| Q1 2021 | $916,000 | -35.0% | 58,226 | 0.0% | 0.03% | -34.6% |
| Q4 2020 | $1,410,000 | +29.5% | 58,226 | -10.0% | 0.05% | -21.2% |
| Q3 2020 | $1,089,000 | -15.6% | 64,683 | +46.9% | 0.07% | -25.0% |
| Q2 2020 | $1,291,000 | – | 44,024 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |